Clinical Trial Update: S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin, capecitabine, and cetuximab with radiation therapy, followed by surgery, in patients with Stage II/III rectal cancer. Resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-24